Skip to main content
Allogene Therapeutics, Inc. logo

Allogene Therapeutics, Inc. — Investor Relations & Filings

Ticker · ALLO ISIN · US0197701065 US Manufacturing
Open in API
Filings indexed 523 across all filing types
Latest filing 2023-06-15 Director's Dealing
Country US United States of America
Listing US ALLO

About Allogene Therapeutics, Inc.

https://allogene.com/

Allogene Therapeutics, Inc. is a clinical-stage immuno-oncology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies. The company engineers T cells from healthy donors to create "off-the-shelf" treatments for cancer and autoimmune diseases. This approach is designed to enable on-demand availability, scalability, and reliability, contrasting with autologous therapies that use a patient's own cells. Allogene's pipeline utilizes multiplex gene-engineering and gene-editing capabilities. Its key investigational programs include cemacabtagene ansegedleucel (cema-cel) for large B-cell lymphoma, ALLO-316 for clear cell renal cell carcinoma, and ALLO-329 for autoimmune disease.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2023-06-15 English
PRIMARY DOCUMENT
Director's Dealing
2023-06-15 English
PRIMARY DOCUMENT
Director's Dealing
2023-06-15 English
PRIMARY DOCUMENT
Director's Dealing
2023-06-15 English
PRIMARY DOCUMENT
Director's Dealing
2023-06-15 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 13, 2023, reporting the results of the 2023 Annual Meeting of Stockholders of Allogene Therapeutics, Inc. It includes detailed voting results for director elections, advisory approval of executive compensation, and ratification of the independent auditor. The content focuses on the submission of matters to a vote of security holders, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements. The document is not a full annual report, earnings release, or management discussion, but specifically reports voting outcomes from the AGM. Therefore, the appropriate classification is DVA (Declaration of Voting Results & Voting Rights Announcements). The document length and detail support a high confidence score.
2023-06-15 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.